论文部分内容阅读
目的:探讨联合应用盐酸莫西沙星和康妇消炎栓治疗盆腔炎的效果。方法:对2014年2月至2015年1月我院收治的60例盆腔炎患者的临床资料进行回顾性分析,将其根据治疗方案的不同分为对照组与观察组,每组患者各30例。为对照组患者使用盐酸莫西沙星进行治疗,为观察组患者联合使用盐酸莫西沙星和康妇消炎栓进行治疗,然后对比分析两组患者的临床疗效及发生不良反应的情况。结果:与对照组患者相比,观察组患者治疗的总有效率较高,差异显著(P<0.05),有统计学意义。与对照组患者相比,观察组患者在进行治疗后其包块的吸收率较高,并发症的发生率、病情的复发率及进行手术治疗的几率较低,差异显著(P<0.05),有统计学意义。结论:联合应用盐酸莫西沙星和康妇消炎栓治疗盆腔炎的效果理想,可显著改善患者的临床症状,降低其病情的复发率、进行手术治疗的几率及并发症的发生率,此法值得在临床上推广应用。
Objective: To explore the combined application of moxifloxacin hydrochloride and Kang Fu anti-inflammatory suppository in the treatment of pelvic inflammatory disease. Methods: The clinical data of 60 patients with pelvic inflammatory disease admitted in our hospital from February 2014 to January 2015 were retrospectively analyzed. According to the different treatment plans, the patients were divided into control group and observation group with 30 cases in each group . The patients in the control group were treated with moxifloxacin hydrochloride. The patients in the observation group were treated with moxifloxacin hydrochloride and Kangfu anti-inflammatory suppository. The clinical efficacy and adverse reactions of the two groups were compared. Results: Compared with the control group, the total effective rate of the treatment group was significantly higher (P <0.05), which was statistically significant. Compared with the control group, the patients in the observation group had a higher rate of absorption after the treatment, the incidence of complications, the relapse rate of the disease and the chance of surgical treatment were lower (P <0.05) There is statistical significance. Conclusion: The combination of moxifloxacin hydrochloride and Kangfu anti-inflammatory suppository is effective in treating pelvic inflammatory disease, which can significantly improve the clinical symptoms, reduce the recurrence rate of the disease, the probability of surgical treatment and the incidence of complications, this method is worth Promote the clinical application.